General Information Treatment Advantage

General Information

TomoTherapy® and Radixact™ Advantages

The TomoTherapy® System is a clinically proven, effective treatment platform for tumors throughout the body and can improve patients' quality of life.

  • What Makes TomoTherapy® Different?

    The TomoTherapy® System is versatile and efficient, enabling delivery of highly effective radiation therapy to a wide range of patients and disease types, from the routine to the complex, while minimizing side effects. The TomoTherapy System is uniquely integrated so that treatment planning, quality assurance, CT imaging, data management and treatment delivery share a common database and a single user interface. A CT scanner-based platform enables treatment delivery from 360 degrees around the patient. The TomoTherapy System is so precise it can often be used to treat tumors that have reoccurred, even in those patients who are not candidates to receive additional radiation from traditional delivery systems.

  • What TomoTherapy® Technology Means to Patients

    One of the most innovative and precise radiation therapy systems available, the TomoTherapy System enables clinicians to customize treatment plans to each patient’s unique needs, and relies on integrated imaging to verify tumor position to ensure accurate radiation delivery at each treatment.

    The TomoTherapy System is a radiation delivery system that efficiently treats cancer anywhere in the body. Designed like a CT scanner, the TomoTherapy System uses integrated imaging to enhance treatment accuracy and a unique beam delivery approach to improve treatment precision. Together, these features enable clinicians to customize treatments for each patient, minimizing exposure to surrounding healthy tissue, which can result in fewer side effects.

    The TomoTherapy System can be used for virtually any case for which radiation therapy is prescribed, including those involving large tumors or multiple tumors throughout the body.

    The TomoTherapy System may be used as the only treatment, or in combination with surgery and/or chemotherapy.

    Hundreds of scientific papers have been written on the use of the TomoTherapy System in clinics worldwide. Many show how its unique design results in superior treatment plans and improved clinical outcomes compared with traditional radiation therapy.

  • Radixact™ Treatment Delivery System

    The new Radixact System is a uniquely smart radiation therapy system that enables optimal treatment for more patients.  The Radixact System is the next generation TomoTherapy platform, designed to enable doctors to more efficiently and effectively deliver precise radiation treatments to more patients.

    The new Radixact Treatment Delivery System features fully integrated treatment delivery, treatment planning and data management systems. All of these highly advanced system components work together seamlessly to automate the most important functions – including automation of treatment workflow processes and exportation of data to the OIS. Designed to provide clinicians with the imaging capabilities, treatment flexibility and precise dose delivery you've come to expect with the TomoTherapy® Treatment System, with the addition of components which will significantly enhance interoperability and increase patient throughput.

1. Franco et al. Journal of Cancer Research and Clinical Oncology. Intensity-modulated and hypofractionated simultaneous integrated boost adjuvant breast radiation employing statics ports of TomoTherapy (TomoDirect): a prospective phase II trial

2. Zeidan et al. International Journal of Radiation Oncology, Biology and Phys. Vol 67 No 3 pp 670 – 677 2007. Evaluation of Image-Guidance Protocols in the Treatment of Head and Neck Cancers 3. O’Donnell et al. Clinical Oncology 2009 21: 294-301. Early Experience of TomoTherapy-based Intensity-modulated Radiotherapy for Breast Cancer Treatment.

4. Tomita et al. Journal of Cancer Research in Clinical Oncology. July 2012 Preliminary results of intensity-modulated radiation therapy with helical tomotherapy for prostate cancer.

5. Customer Loyalty Data. August 2012

6. Van Prijs et al. Radiation Oncology 2012, 7:80. Short course radiotherapy with simultaneous integrated boost for stage I-II breast cancer, early toxicities of a randomized clinical trial

7. Michalski et al. Medical Dosimetry 2013. A dosimetric comparison of 3D-CRT, IMRT and static tomotherapy with an SIB for large and small breast volumes.